Pharma Journalist

2nd Annual CKD3 Summit
2019-05-06 - 2019-05-08 | Revere Hotel Boston Common, 200 Stuart St, Boston, MA, 02116, United States
Chronic Kidney Disease Drug Development (CKD3) is a uniquely focused conference that unites key opinion leaders in this field to identify and discuss the critical factors determining the success of current CKD pipelines and significantly impact the standard of care for this huge unmet medical need.

Bringing together leading experts from innovative biotechs, large pharma, academia and key service provider companies, CKD3 will present comprehensive insight into the cutting edge progress of CKD drug development research.
To learn more and to register online, visit https://ter.li/10so2k

Clinical Operations in Oncology Trials to the West Coast 2019
2019-04-30 - 2019-05-01 | Burlingame, California
Arena International is excited to announce the return of the 6th Annual Clinical Operations in Oncology Trials to the West Coast on April 30th – May 1st 2019.
As one of the only oncology operationally focused events in the West Coast, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage West Coast physicians and patients.
The event will be led by a myriad of industry specialists from the West Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion, spotlight Q&As, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market.
While maintaining the primary focus of its previous years, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry, and provide insight into the latest technological and therapeutic solutions.
We hope to see you in April, make sure to register your place today!

European NeoAg Summit
2019-04-23 - 2019-04-25 | Amsterdam Marriot Hotel Stadhouderskade 12, 1054 ES Amsterdam, Netherlands
With an exclusive case-study led agenda, the European NeoAg Summit will paint a fuller picture of neoantigen presentation and T-cell interaction. Hear updates on clinical trials results to help you further determine neoantigen immunogenicity.
In addition, gain practical insights on personalised cancer vaccine and cell therapy global clinical development, as well as regulatory guidance.
Join the gathering of over 100 personalised cancer immunotherapy pioneers from pharma and biotech including Ziopharm, Genocea, Vaccibody and more to advance neoantigen based cancer vaccines and cell therapies.
For more information, visit www.neoantigen-europe.com

Neuroimmunology Drug Development Summit (NIDD)
2019-04-16 - 2019-04-18 | Hyatt Regency Boston One Avenue de Lafayette, Boston Massachusetts, United States, 02111
Built with thought-leaders at Sanofi, Eisai, AbbVie and Denali, the inaugural NIDD Summit will share the field’s cutting-edge scientific advances enabling you to translate your neuroimmunology research into a clinically effective therapeutic for neurological diseases.

With an emphasis on neurodegeneration, chronic neuroinflammatory mechanisms will be explored whilst addressing your drug development challenges:

Discover robust biomarkers of neuroinflammation to enable successful translation and patient stratification
Navigate preclinical model limitations to better predict clinical efficacy
Explore the identification and validation of neuroimmunological targets and assess novel therapeutic approaches

Don’t miss this opportunity to learn from 20+ industry expert speakers to effectively target neuroimmunological mechanisms and rapidly progress your research to the clinic.
For more information, visit www.neuroimmunology-drugdevelopment.com

CAR-T Congress USA
2019-04-16 - 2019-04-17 | Hyatt Regency Boston Harbor, 101 Harborside Drive, Boston, MA, 02128, United States
CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite, the race is on to lead the commercialization of safe, efficacious and accessible CAR-T therapy.

The fourth annual CAR-T congress USA provides a platform for emerging novel data in small scale clinical trials ran by the leading academic institutions, including MD Anderson and the University of Pennsylvania.
Hear first-hand, the emerging areas of research from new companies into single patient experiences, as well as context around patient relapses and methods of toxicity management.
Join thought leaders from biotechs, pharmaceutical companies and academia to address the challenges of CAR-T therapy including toxicity, scalability and efficacy in both liquid and solid tumours.
Discover how CAR-T compares to standard treatments and advances in genome editing tools, the new methods in allogeneic and autologous process development and the pre-clinical concepts that will pave the way for novel antigen discovery.
Be part of the movement that engineers a strategy to reprogram the cancer treatments we know today.
Book before January 25 to save up to $800. To learn more about this event and to book online visit: www.car-tcongress.com/register

17th annual eyeforpharma Philadelphia Conference
2019-04-16 - 2019-04-17 | Pennsylvania Convention Center, 1101 Arch St, Philadelphia, PA, 19107, United States
Where pharma’s performance is built by patient value
The world’s greatest gathering of pharma’s value-designers
Every important industry player in one room, evolving our antiquated model by embracing value-based care. That’s the vision for eyeforpharma Philadelphia, the flagship event where pharma, patients and payers co-design for outcomes.
There are dozens of events on digital, on patient centricity, on data, on access, on medical, on commercial. Only one event brings all the key designers together so that we can address unmet need, create solutions that cover the spectrum, and end the age-old problems of misalignment.
Join us for pharma’s most influential meeting – as we write the blueprint for healthcare’s future.
To learn more about this event, and to register online, visit http://bit.ly/2O8ldd5

Adaptive Designs in Clinical Trials 2019
2019-04-01 - 2019-04-02 | Holiday Inn Kensington Forum, 97 Cromwell Road, London, SW7 4DN, United Kingdom
SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials – demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology.

Hosting in depth presentations from regulatory agencies, researchers and biostatisticians, the meeting will cover how personalized medicine, platform trials, response-adaptive randomization, signature designs, estimand framework, Bayesian methods and digital innovation are revolutionizing the drug development process both in Europe and North America.
To learn more and to register online, visit www.adaptivedesigns.co.uk/pharmajwl

The Pharma Gorilla
2019-03-27 | Hilton Mumbai International Airport, Mumbai, India
The Pharma Gorilla will be held on March 27, 2019 in Hilton Mumbai International Airport, Mumbai, India. It provides the opportunity to learn, engage and network for the pharmaceutical and healthcare fraternity. This conference is designed to address practical issues and topics for Corporates, scientists, professors, business representatives, and healthcare providers to discuss the latest innovations, trends and concerns, practical challenges and solutions in Pharma.
The objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends, advancements, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry.
The Pharma Gorilla provides a perfect platform for conducting presentations, keynote sessions, sharing the knowledge, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition.

Clinical Trial Supply New England 2019
2019-03-26 - 2019-03-27 | Boston, Massachusetts
This year’s Clinical Trial Supply New England celebrates its 8th year and will be hosted on the 26th – 27th of March.
In 2019 we have worked hard to prepare a leading industry agenda which makes this event a must attend in the industries calendar. We have built on last year’s success conference and are returning with full force to Boston with the aim of supporting trial sponsors and solution providers across New England to ensure trials are delivered on time, partnerships are improved and supply chain uncertainties are resolved.
We will once again be meeting in to discuss, deliberate and debate the latest operational and technological challenges with regards to clinical trial supplies. Over the course of two days you can expect to catch-up with old colleagues and make new lasting business connections to help drive success in your trials. As Arena’s dedicated Clinical Trial Supply conference for the New England area, this event caters to local needs while offering the change to meet international sponsors and solution providers.
At each Clinical Trial Supply conference we create a welcoming networking environment and an educational program packed with the latest case studies, techniques and providers to set your trial apart. This year is no different as we have a vast array of fascinating case-studies, thought leading presentations and engaging panels.
This year we will be looking at those issues which are affecting companies in the Boston-Cambridge hub, such as but no limited to: ways to move beyond the theory; harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain, discovering how to incorporate gene therapies within your supply chain and blockchain: a discussion of practical applications for clinical supply chain and life-sciences.
With such a packed program you can’t afford to miss out. We look forward to meeting you in Boston so make sure to book your place today!

Gene Therapy for Rare Disorders
2019-03-26 - 2019-03-28 | The Westin Boston Waterfront, 425 Summer St, Boston, MA, 02210, United States
Gene Therapy for Rare Disorders is a uniquely focused conference that unites the leaders in the field to identify and discuss the critical factors that will influence genetic treatments most significantly in the near future.

Incorporating insights from 50+ industry-leading speakers, the meeting delves into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.
Bringing together leading experts from innovative biotechs, large pharma, academia and key service provider companies, Gene Therapy for Rare Disorders will present a comprehensive insight into the cutting edge progress of gene therapies combatting rare disease.
Join 350+ of your colleagues to accelerate the progress of the next generation of gene therapies that show improved efficacy, enhanced safety and commercial viability.
To learn more and to register online, visit https://bit.ly/2ByuEe2

Innate Killer Summit 2019
2019-03-19 - 2019-03-21 | Hilton San Diego Gaslamp Quarter, 401 K St, San Diego, CA 92101
Accelerate to Market Genetically Engineered, Off-the-Shelf and Cost Effective NK Cell Immunotherapies for Solid Tumor Indications
The Innate Killer Summit 2019 discusses safer, more cost-effective and potentially more efficacious NK cell immunotherapy as the next generation of frontline cancer therapy.

It will help you to optimize your manufacturing and process development strategies to further reduce the cost of off-the-shelf NK cell therapies. Discuss the most up to date clinical data on genetically engineered NK cells from CARs to bispecific engagers and ensure persistence and durability.
Bringing together over 100 of the field’s leading minds to share experience and knowledge on the optimal NK cell source and improve the efficacy of NK cell therapies through enhanced targeting methods. Join us at the 4th Annual Innate Killer Summit to bring to patients the next generation of cell immunotherapies that are safer and cheaper.

Pharma Security World 2019 - Anti-Counterfeiting, Drug Serialization and Supply-Chain Security Conference
2019-03-19 - 2019-03-20 | London, United Kingdom
The Counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores. What’s more, pharmaceutical companies and regulators are creating ways to stop them. No nations stay untouched by this issue, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters. To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Security World 2019 – Supply-Chain, Drug Serialization and Anti-Counterfeiting Conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.

ePharma IMPACT
2019-03-19 - 2019-03-21 | NY Hilton 1335 Ave of the Americas New York, NY 10017, NY, United States
ePharma IMPACT brings together the most influential players across the digital marketing spectrum to reveal truly innovative, next generation omni-channel strategies.
The 3-day event is designed to help you take command of the most influential strategies on the horizon so you can confidently determine where your next digital marketing dollar should be spent for maximum impact.
How do we deliver on that promise? By offering a diversified experience like you won’t find anywhere else. One that translates directly into stronger patient and HCP relationships, and greater influence over impactful marketing strategy.
The 12th annual conference is THE event leading pharma companies rely on to stay ahead of digital disruption and translate digital marketing strategies into bottom line impact.

ProcureCon Pharma 2019
2019-03-19 - 2019-03-20 | Steigenberger Frankfurter Hof, Am Kaiserplatz, Frankfurt/Main, 60311, Germany
Taking place on 19th-20th March 2019 in Frankfurt, ProcureCon Pharma is the only Conference for CPOs & Senior Procurement Executives from leading pharma Companies

Join 150+ senior procurement professionals from Merck, AstraZeneca, Roche, Sanofi, Lonza and other world leading Pharma businesses over 2 days and 40 interactive sessions that will help you make better outsourcing decisions, speed up transformation and co-create value with business partners. To learn more about ProcureCon Pharma, download the agenda.
Take away solutions to all of your top challenges:

Master analytical and digital procurement in pharma
Build strategic partnerships with your internal stakeholders
Design and train a high-performing global pharma procurement team
Move beyond savings with key CROS and CMOS to unlock hidden innovation

For more information including the incredible speaker line-up, take a look at the conference brochure here: https://bit.ly/2yIP6a1
Book your place online today: https://bit.ly/2PvKzS8 and get 15% off the current ticket price with our exclusive discount code – “PCPPJ15”

3rd Annual Drug Discovery Chemistry
2019-03-18 - 2019-03-19 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi’s 3rd Annual Drug Discovery Chemistry
Developing your R&D pipeline with strategies to deliver small molecules
Conference: 18 – 19 March 2019
Workshop: 20 March 2019
Location: Copthorne Tara Hotel, London, UK
Website: www.drug-discovery.co.uk/PJwl
CHAIRED BY:
Roderick Hubbard, Senior Fellow, Vernalis Research Ltd
Darren Green, Director of Molecular Design, GSK
SMi is proud to present its 3rd Annual Drug Discovery Chemistry event, taking place on the 18th-19th March 2019.

The fight to optimise the drug discovery process is on as there is currently a reduced output of new medicines within the market, however, demand for novel drugs is still steadily increasing.M
This year’s event will specifically focus on innovations within the field that has the potential to drive the pharmaceutical industry into a new era of medicines, with optimization of the R&D process to become cheaper, faster and increasing the likelihood of drug efficacy and success. These are some of the major obstacles within drug discovery at present, as the process is overall long, expensive and often potential drugs will fail late in clinical trials, wasting resources and time.
The event will also focus on novel techniques that can be implemented within the field today that can identify new druggable targets and possibly open new therapeutic areas within the clinic. This could offer opportunities for pharmaceutical companies to produce medicines for diseases and ailments that have previously not been targeted, and likewise, offer new drug targets for existing diseases that could potentially offer better clinical outcomes, such as within the development of cancer drugs.
Drug Discovery Chemistry 2019 will look at various developments within the field, guiding companies on how they can best utilize the newest technologies and drug discovery modalities to develop new medicines, reduce their R&D cost and timelines, and ultimately, increase their medicine output for commercial success.
Event Hashtag: #SMiDrugDisChem
KEY SPEAKERS INCLUDE:

Vivek Vishnudas, Senior Vice President Drug discovery & Platform Sciences, Berg LLC
Tobias Gabriel, Global Head of Discovery Chemistry, Novartis
Govinda Bhisetti, Principal Investigator and Head of Computational Chemistry, Biogen
Hasane Ratni, Expert Scientist, F Hoffmann-La Roche
Alexander Hillisch, Director of Medicinal Chemistry, Bayer

KEY TOPICS FOR 2018 INCLUDE:

Discuss the impact of the use of novel computational techniques on R&D pipelines
Hear about the progress in the development of new drugs on difficult targets and how these can revolutionise patient treatment
Discover how AI is being utilised in the commercial setting and opportunities to best exploit these to streamline the Drug Discovery Process
Explore the potential of new modalities to transform therapeutics
Learn about current strategies to increase drug discovery success

Post conference workshop on 20 March 2019
Artificial Intelligence in Drug Discovery
Led by: Nick Camp, Consultant
WHO SHOULD ATTEND
CEOs, Presidents, Vice Presidents and Global Heads, Executive Directors, Vice President & Global head, Principal Scientists, Heads of Business Development, Directors of Pharma/Biotech firms.
EARLY BIRD-RATES

BOOK BY 30 NOVEMBER AND SAVE £400
BOOK BY 15 DECEMBER AND SAVE £200
BOOK BY 31 JANUARY AND SAVE £100

21st Annual Superbugs & Superdrugs Conference
2019-03-18 - 2019-03-19 | HOLIDAY INN KENSINGTON FORUM, 97 Cromwell Road, London, SW7 4DN, United Kingdom
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections.

SMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London, UK for its 21st year running, on the 18th & 19th March 2019. This year’s event aims to provide valuable insights and key updates on the latest developments within the scientific communities, as well as the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections.
The two-day conference will also host a diverse gathering of policy makers and economists, in addition to big pharmas and biotechs, who will discuss incentives, partnerships, regulations and new policies. Industry experts and scientific pioneers are set to present on their research advances and clinical data, as well as alternatives to antibiotics, such as monoclonal antibodies and antimicrobial peptides.
2019 HIGHLIGHTS:

Analyse the current status of antimicrobial resistance with industry-led insight into current strategies to tackle AMR
Hear about novel immune-therapeutics to target Gram-negative bacterial infections
Learn about strategies to combat β-lactamases
Evaluate the development of precision antibiotics: Agents designed to meet the demands of stewardship
Explore the role of plasmids in the evolution of antimicrobial resistance

Join us in London next year to explore the challenges and solutions to the growing threat of antibiotic resistance, as well as take part in interactive roundtable discussions with leading organisations. Attendees will also have the exclusive opportunity of networking with an unrivalled gathering of senior experts from Chemical Biology Ventures, University of Oxford, MedImmune, HPRA, GARDP, DNDi, Bioharmony Therapeutics, and many more.
Early Bird Discounts!
Book by November 30th and save £400
Book by December 14th and save £200
Book by January 31st and save £100
For more information and to register online, please visit http://www.superbugssuperdrugs.com/pjwl

2nd Annual Pharma Regulatory Summit 2019
2019-03-14 | Kohinoor Continental Hotel, Mumbai, India, Mumbai, India
Pharma Regulatory Summit is the leading platform for regulatory experts, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations in the region. This conference will focus on the new strategies, amendments, innovations, developments in the fields of regulatory affairs, intellectual property and medical devices, which reflects new strategies in the field of regulatory affairs.
SPONSORS:

Exhibitor: Nishith Desai Associates

CONFERENCE REGISTRATION PROCESS:
E-mail – kavitha@virtueinsight.co.in Tel: +9144 24762472

Early Bird Discount Price (Ends 28th January 2019) – (INR 10,000 + GST (18%) per delegate)
Standard Price (From 29th January 2019 Onwards) – (INR 15,000 + GST (18%) per delegate)
Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available

Get more from the event, with a broader scope bringing the whole communications value chain together.

Clinical Trial Supply Europe 2019
2019-03-13 - 2019-03-14 | Milan, Italy
This year’s Clinical Trial Supply Europe celebrates its 20th year! As a result of this special occasion we have worked hard to prepare a leading industry agenda which makes this event a must attend in the industries calendar. We have built on last year’s incredibly successful conference and are returning with full force to Milan with the aim of supporting trial sponsors and solution providers across Europe to ensure trials are delivered on time, partnerships are improved and supply chain uncertainties are resolved.

We will once again be meeting in Milan, Italy, to discuss, deliberate and debate the latest operational and technological challenges with regards to clinical trial supplies. Over the course of two days you can expect to catch-up with old colleagues and make new lasting business connections to help drive success in your trials. As Arena’s largest CTS conference this event promises to be a must attend for the industry!
At each Clinical Trial Supply conference we create a welcoming networking environment and an educational program packed with the latest case studies, techniques and providers to set your trial apart. This year is no different as we have a vast array of fascinating case-studies, thought leading presentations and engaging panels.
This year we will be looking at issues such as, but not limited to discovering the practical benefits of e-labelling; how this technological innovation can expedite packaging and labelling timelines, ways to move beyond the theory; harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain and whether blockchain’s time come? Is blockchain a buzzword or an actionable tool for disrupting operations?
With such a packed program you can’t afford to miss out. We look forward to meeting you in Milan so make sure to book your place today!

Temperature Controlled Logistics in Biopharmaceuticals Europe 2019
2019-03-13 - 2019-03-14 | Milan, Italy
Facilitating a platform for the pharmaceutical industry to refine their temperature controlled logistics strategy to ensure an overall successful supply chain

The 15th Annual Temperature Controlled Logistics in Biopharmaceuticals returns to Milan, after an extremely successful 2018 event. The largest European clinical and commercial pharmaceutical supply chain will bring together industry experts to examine the ever changing market and how these new dynamics will impact how the sector operates.
Our 2019 agenda will focus on providing a holistic approach to the pharmaceutical supply chain to ensure the quality, efficacy and safety of your product during temperature controlled shipments.
Avoiding death by power point our 2 day event will facilitate interactive and engaging sessions from panel discussions, roundtables, fireside chats and case studies to give rise to innovation solutions to existing challenges.
Key topics for 2019 will include:

Developing risk mitigation management plans
Refining your shipping lines to reduce temperature deviations
Adding metrics whilst comparing air, rail and sea distribution to determine the best transportation method for each product
Separating the hype to give rise to practical tangible solutions of how to incorporate blockchain into your supply chain

Join us in March to be a part of the discussions to refine your temperature controlled logistics strategy. Click here to book your place now

Outsourcing Clinical Trials Israel 2019
2019-03-12 - 2019-03-13 | We are pleased to announce the venue is now confirmed. To request the venue details please contact us at events@arena-international.com
Arena International is thrilled to announce that the fifth Outsourcing in Clinical Trials conference is returning to Tel Aviv, 12th – 13th March, 2019, the only clinical outsourcing platform for biotech, pharmaceutical and medical device companies within Israel.
As with its reputation, this conference addresses how companies can effectively develop their outsourcing strategies and attendees with attain an increased understanding of how to enhance their operational efficiencies to ensure timely and cost-effective clinical studies.
This conference is equally an exclusive place in which delegate will network with industry professionals and service providers, as well as attending insightful lectures from senior representatives from entrepreneurial companies within the Israeli Life Sciences sector.
We invite you to join us in March 2019, register your place today.

CPhI South East Asia 2019
2019-03-12 - 2019-03-14 | Queen Sirikit National Convention Center (QSNCC), 60 New Rachadapisek Road, Klongtoey, Bangkok, 10110, Thailand
CPhI South East Asia will move to Bangkok, Thailand in March 12-14 for the first time. Featuring the co-located with FDF, ICSE, P-MEC, InnoPack, and LABworld South East Asia, CPhI South East Asia 2019 will host more than 6,000 attendees and 270 exhibitors. CPhI South East Asia offers you the chance to do business in a booming and expanding market, meet the movers and shakers of the South East Asian pharma industry and keep up to date with trending news and topics.
Whether you are looking for sourcing new business or getting the latest market insight, this is your ONE-STOP – SHOP pharmaceutical platform in South East Asia.
To learn more about this event, visit www.cphi.com/sea

AsiaTIDES: Oligonucleotide & Peptide Therapeutics
2019-02-26 - 2019-02-28 | Hilton Tokyo Bay Hotel | Tokyo, Japan
AsiaTIDES is the only event in Asia that brings together the science, technologies and partners you need to accelerate your oligonucleotide and peptide molecules to market. Join 300+ scientists and executives at this upcoming meeting featuring keynote speakers from Novo Nordisk A/S, Ionis Pharmaceuticals, Alnylam Pharmaceuticals, and WAVE Life Sciences.

Register now at www.AsiaTIDESEvent.com with code “PHARMJ10” and SAVE 10%.

Global NASH Congress
2019-02-25 - 2019-02-26 | London, United Kingdom, London Heathrow Marriott Hotel, London, United Kingdom
Attracting experts working in all areas of nonalcoholic steatohepatitis, the Global NASH Congress will examine the latest research and development in pathogenesis, diagnosis, and treatment of the disease. An increasing number of people are being diagnosed with the nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) each year, and the primary method of treatment is weight loss. With no approved medicines on the market, the drug development race is intensifying. The pathogenesis of NASH is still not fully understood, and definitive diagnostic methods are invasive, so development has been slow. There are, however, promising developments in research that will hopefully bolster drug development and other methods of treatment. Examples of such developments include improved in vivo liver models, non-invasive diagnostic biomarkers and a better understanding of the disease’s mechanisms. This year’s congress will focus on these exciting advancements, as well as on the challenges of preclinical and clinical research in NASH. There will also be a session on business development/regulation and a showcase of the most promising therapeutics in development.

CAR-TCR Summit Europe
2019-02-25 - 2019-02-27 | Novotel London West, 1 Shortlands, Hammersmith, London, W6 8DR, United Kingdom
The industry-focused CAR-TCR Summit Europe is dedicated to developing, translating and delivering next generation CAR and TCR therapies for patients in Europe.

Join over 250 of Europe’s leading drug developers to learn about never-before-seen clinical updates and novel technology to improve solid tumour targeting, advance allogeneic therapy development and automate manufacturing processes in order to create a targeted, efficacious and commercially viable cancer therapy.
For more information, visit www.cartcr-europe.com

3rd European Clinical Quality Oversight Forum
2019-02-25 - 2019-02-26 | Hilton London Canary Wharf, South Quay, Marsh Wall, London, E14 9SH, United Kingdom
The European Clinical Quality Oversight Forum in London is the ONLY European event dedicated to risk-based approaches for selecting, managing and monitoring clinical vendors and sites. This interactive event focuses on ensuring trial integrity by effectively assessing, optimising and managing the quality of clinical vendors and sites.

To learn more about this event, visit https://goo.gl/uPWwum

Pharma Packaging and Labeling East Coast 2019
2019-02-20 - 2019-02-21 | Philadelphia, Pennsylvania
Now in its 11th year, Pharma Packaging and Labeling is back to deliver key, actionable insights into very latest regulatory requirements, technological innovations, strategic developments, and how to implement them into your packaging and labeling chain with both maximum efficiency and minimal cost.

With evolving regulations and tougher anti-counterfeiting rules, ensuring patient safety and the right systems are in place is more crucial than ever. Meeting the deadlines and adhering to regulations will not only ensure compliance but will also deliver huge benefits to your business and the industry
With popular demand, the US Drug Enforcement Agency will be back to answer questions on current anti-counterfeit regulations and how this will impact your business. The 2019 speaker line up brings together regulatory bodies and pharma companies including the DSCSA, US Customs & Borders, Pfizer, Merck, Trevena, Biogen, Alkermes and an insight into CMOs including PharmoRx Therapeutics, among many others.
Pharma Packaging and Labeling will bring you everything you need to ensure a successful and compliant implementation for your packaging and labeling. With a more interactive and hands on agenda including panel discussions; roundtables; speed networking; think tanks; mini workshops and more, this event will create an environment where commercial packaging and labeling teams from across all sizes of manufacturer can work together to manage creative, technical, and regulatory demands while ensuring patients are safeguarded at all stages.
For more details, please visit http://www.arena-international.com/pharmapackagingeast/

3rd Annual 3D Cell Culture
2019-02-20 - 2019-02-21 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi’s 3rd Annual 3D Cell Culture
Delivering updates on the development and application of human organs and tissues in vitro

Proudly sponsored by InoCure & TEDD Competence Centre
CHAIRED BY:
Nicola Valeri, Gastrointestinal Cancer Biology and Genomics Team Leader, The Institute of Cancer Research
Stefan Przyborski, Professor of Cell Technology, University of Durham
Cell Culture in an important tool for research and development within the life science industry. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers over conventional cell culture methods. 3D cell culture enables cells to grow and interact with their surroundings in all three dimensions, better mimicking the in-vivo conditions in which the cells are naturally present. This enhances the ability for scientists to study basic biological mechanisms such as cell number monitoring, cell viability, proliferation and morphology. 3D cell cultures also have greater stability and longer life spans.

Researchers globally are realizing the potential of 3D cell culture for various applications, including testing and discovering new drugs to treat cancer, organ-on-chip models to study the human physiology in an organ specific context, and 3D cell printing to produce organ models. Therefore, this market is likely to grow over the next few years and is in fact projected to reach USD 1.7 Million by 2022, growing at a CAGR of 20.3% between 2017-2022. Growth in this market is also driven by global factors such as a need for alternative methods to animal resting, funding from governments and private entities and technological advancements in the field.
At the 3D Cell Culture Conference in February, we will look at the latest developments in the 3D Cell Culture field. Participants will have the opportunity to network with industry experts, gain insight into how the pharmaceutical industry is utilizing 3D Cell Culture technologies to enhance research and development, discuss the potential for novel in-vitro cell culture models to replace animal models, and discover novel 3D cell culture systems, organ-on-chip, 3D imaging of organoids and other technologies in development.
Event Hashtag: #SMi3DCellCulture
FEATURED SPEAKERS INCLUDE:
GUEST SPEAKER:

Bill Mattes, Director, Division of Systems Biology, FDA

SPEAKERS INCLUDE:

Asli Akidil, Cell and Molecular Scientist, AstraZeneca
Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Biosciences
Jason Ekert, Head of Complex In Vitro Models, GSK
Philip Hewitt, UK and Eurotox Registered Toxicologist, Head of Early Investigative Technology, Merck
Stefan Kustermann, Lab Head, Investigative Safety, Roche
Veronique Barban, Expert Virology, Research and Nonclinical Safety Department, Sanofi Pasteur

KEY TOPICS FOR 2018 INCLUDE:

Organ-on-chip technologies and their applications in the pharmaceutical industry
Panel discussion on whether 3D Cell Culture will replace animal models
Determining the predictive validity of 3D models and achieving standardization for preclinical testing
Global developments in 3D Cell Culture and how this exponential growth will impact researchers
Several novel techniques for imaging of 3D Cell Cultures
Development of 3D eye models for early assessment of retinal toxicity
Musculoskeletal regeneration harnessing preclinical models for tissue repair

View the full agenda: http://www.3d-cellculture.com/pjwl
WHO SHOULD ATTEND
Biotech / Pharma Companies – Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist
Academia Professor – Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering
Solution Providers – Manager, Head of, CEO, Director, Founder, Account Manager, President, CSO, Executive, Managing Director, Vice President, COO
Organisations / Regulatory – Director, Senior Science Advisor, Scientific Officer
EARLY BIRD-RATES

BOOK BY 31ST OCTOBER AND SAVE £400
BOOK BY 30TH NOVEMBER AND SAVE £200
BOOK BY 14TH DECEMBER AND SAVE £100

7th World CNS Summit
2019-02-19 - 2019-02-21 | Seaport Hotel & World Trade Center, One Seaport Lane, Boston, MA, 02210, United States
The 7th World CNS Summit is the only industry-specific conference exclusively focused on advancing translational neurodegenerative research.

World CNS’s mission is to reinvigorate drug discovery and development across multiple neurodegenerative disorders by providing an interactive environment that ensures thought-provoking discussions and unparalleled networking opportunities for all of our attendees, helping to overcome the translational challenges in developing efficacious therapeutics.
Developed in combination with experts from Biogen, Eisai, Merck, AbbVie and other leading organizations, the World CNS Summit uniquely combines distinct neurodegenerative diseases in one setting to examine mechanisms of disease and emerging strategies for targeting.
Following numerous neurodegenerative disease clinical failures, the neurodegenerative disease field requires a refreshed approach towards drug development to drive clinical success.
Now in its 7th successful year, the World CNS Summit challenges traditional thinking to guide drug development of efficacious treatments for neurodegeneration, bringing together over 150+ leading minds in the neurodegenerative space, from academia, pharma, biotech and leading consortia, to provide a unique opportunity to bridge the gap of translational drug development.
To learn more and to register online, visit http://bit.ly/2AfTc9J

Pharma Security Asia 2019
2019-02-19 - 2019-02-20 | Singapore, Singapore
The importance of the pharmaceutical industry in the modern-day Asian society cannot be overstressed especially as there are new diseases springing up from different areas, strengthening the importance of adequate drug research and development activities. However, with the growth of the industry in Asia comes the increase in fake drugs. In recent times, these products are still being produced and passed down to consumers in large quantities amidst the impact of the various counterfeiting hubs that have been seen to operate on a global scale. According to World Health Organization (WHO), about ten to thirty percent of the pharmaceuticals distributed to most third world countries are fake and this industry is growing at an alarming rate, even faster than legitimate pharmaceutical companies raking in about $217 billion yearly in sales.
We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.
Thus, To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Security Asia 2019 – An Anti-Counterfeiting, Drug Serialization and Supply-Chain Security Conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.
Social Media:
@corvusglobal
https://www.facebook.com/corvusglobalevents/
https://twitter.com/corvusglobal?lang=en

Outsourcing in Clinical Trials West Coast 2019
2019-02-12 - 2019-02-13 | Hyatt Regency San Francisco Airport Hotel 1333 Bayshore Highway Burlingame 94010
After record-breaking attendance in 2018, Arena International’s flagship Outsourcing in Clinical Trials West Coast conference returns to the Bay Area for its 11th year in February 2019.
With 6 tracks spanning across 2 days, the 2019 event is guaranteed to provide you with practical takeaways to help you accelerate your clinical trial timelines as well as insider knowledge on new innovations and technological advancements in the industry.
Focused on enabling collaboration between the clinical trials community in the Bay Area, the 2019 agenda is jam-packed with interactive sessions such as fireside chats, panel discussions, think-tanks and more. Whether you want to dive into a presentation on digital biomarkers or a panel discussion on measuring the health of your vendor partnerships, there is something for everyone at the upcoming meeting.
Don’t miss out on; join us in Burlingame on 12-13 February by registering your place today!
